Latest news
RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors - Investing News NetworkInvesting News Network · Thu, 06 Aug 2026 22:13:08 GMTHow Desmoid Tumor Treatment Has Changed–And What's Next - Targeted OncologyTargeted Oncology · Wed, 05 Aug 2026 14:39:48 GMTUNC Biochemists Discover New Method to Combat Pediatric Bone Cancer - UNC HealthUNC Health · Mon, 03 Aug 2026 18:48:32 GMTOff-Label Targeted Therapy Presents a Parallel Path to Trials in Sarcomas - Targeted OncologyTargeted Oncology · Mon, 03 Aug 2026 15:07:49 GMT